Boussiotis, Vassiliki A
- Beth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #17,251
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$672.6K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#17,251
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Boussiotis, Vassiliki A as a PI. Multi-PI records show the full award amount for context.
- 1R01CA271601-01A1R01Contact PIUnderstanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.Beth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$672.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Boussiotis, Vassiliki A as a PI.
FY2023 award administered by Beth Israel Deaconess Medical Center (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardBeth Israel Deaconess Medical Center
- 2001Entered Top 50% NationallyRanked #8998
- 2002$500K Cumulative Funding
- 2003$1M Cumulative Funding
- 2005R01 Grant Holder
- 2018$2M Cumulative Funding
- 2022$5M Cumulative Funding